Previous studies of our group demonstrated that PBMT ameliorated dendritic atrophy via upregulation of BDNF [57] and reduced Aβ levels by activating the PKA/SIRT1 signaling pathway in an Alzheimer's disease model [50]. Here, BDNF is linked to early-onset autosomal dominant Alzheimer disease.